Alto Pharmacy Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
832
- Latest Deal Type
-
M&A
- Investors
-
2
Alto Pharmacy General Information
Description
Developer of a digital pharmacy platform designed to provide a convenient and reliable delivery of medicines. The company's tool combines pharmacist care with technology to deliver an affordable experience for those who need medication and offers medication management and scheduled delivery through a web portal or mobile application, enabling patients to find and compare the prices of medications and receive medicines at home.
Contact Information
Website
www.alto.com(Operating Subsidiary)
Corporate Office
- 645 Harrison Street
- Suite 200
- San Francisco, CA 94107
- United States
Corporate Office
- 645 Harrison Street
- Suite 200
- San Francisco, CA 94107
- United States
Alto Pharmacy Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Merger/Acquisition | 21-May-2025 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series F) | 26-Nov-2024 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 11. Later Stage VC | 01-Oct-2023 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 19-Dec-2022 | Completed | Generating Revenue | |||
| 9. Angel (individual) | 13-Apr-2022 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series EE) | 31-Mar-2022 | Completed | Generating Revenue | |||
| 7. Debt - General | 02-Nov-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 30-Jan-2020 | $250M | $360M | Completed | Generating Revenue | |
| 5. Later Stage VC (Series CC) | 01-Jul-2019 | $30M | $110M | Completed | Generating Revenue |
Alto Pharmacy Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F | ||||||||
| Series EE-1 | ||||||||
| Series EE | ||||||||
| Series DD | ||||||||
| Series CC-4 | ||||||||
| Series CC-3 | ||||||||
| Series CC-2 | ||||||||
| Series CC-1 | ||||||||
| Series BB | 5,902,610 | $0.000010 | 6% | $2.91 | $2.91 | 1x | $2.91 | 4.62% |
| Series AA-1 | 774,722 | $0.000010 | 6% | $0.84 | $0.84 | 1x | $0.84 | 0.61% |
Alto Pharmacy Comparisons
Industry
Financing
Details
Alto Pharmacy Competitors (9)
One of Alto Pharmacy’s 9 competitors is Fuze Health, a Venture Capital-Backed company based in Fairfield, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fuze Health | Venture Capital-Backed | Fairfield, OH | ||||
| AnewHealth | Private Equity-Backed | Valley View, OH | ||||
| Drugs.com | Corporation | Auckland, New Zealand | ||||
| PillPack | Formerly VC-backed | Manchester, NH | ||||
| Capsule (Delaware) | Venture Capital-Backed | New York, NY |
Alto Pharmacy Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alto Pharmacy Patents
Alto Pharmacy Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250384987-A1 | Medical prescription review and decision support system | Pending | 14-Jun-2024 | ||
| US-11961599-B2 | Method for authorizing and accessing medication parameters for prescription medications | Active | 16-Nov-2015 | ||
| US-20170193191-A1 | Method for authorizing and accessing medication parameters for prescription medications | Active | 16-Nov-2015 | ||
| US-20170053095-A1 | System and method for tracking medication adherence | Inactive | 19-Aug-2015 | ||
| US-6365629-B1 | Liquid dry emollients | Inactive | 10-May-1999 | A61Q5/02 |
Alto Pharmacy Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alto Pharmacy Former Investors (69)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 10X Capital | Venture Capital | Minority | ||
| Aidenlair Capital | Venture Capital | Minority | ||
| Aito Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Anchor Capital GP | Growth/Expansion | Minority |
Alto Pharmacy Acquisitions (2)
Alto Pharmacy’s most recent deal was a Merger/Acquisition with NowRx (Pharmacy Patient Business). The deal was made on 30-Nov-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| NowRx (Pharmacy Patient Business) | 30-Nov-2022 | Merger/Acquisition | Specialty Retail | ||
| Round Health | 23-Aug-2017 | Merger/Acquisition | Application Software |
Alto Pharmacy FAQs
-
When was Alto Pharmacy founded?
Alto Pharmacy was founded in 2015.
-
Where is Alto Pharmacy headquartered?
Alto Pharmacy is headquartered in San Francisco, CA.
-
What is the size of Alto Pharmacy?
Alto Pharmacy has 832 total employees.
-
What industry is Alto Pharmacy in?
Alto Pharmacy’s primary industry is Clinics/Outpatient Services.
-
Is Alto Pharmacy a private or public company?
Alto Pharmacy is a Private company.
-
What is Alto Pharmacy’s current revenue?
The current revenue for Alto Pharmacy is .
-
How much funding has Alto Pharmacy raised over time?
Alto Pharmacy has raised $763M.
-
Who are Alto Pharmacy’s investors?
10X Capital, Aidenlair Capital, Aito Capital, , and Anchor Capital GP are 5 of 69 investors who have invested in Alto Pharmacy.
-
Who are Alto Pharmacy’s competitors?
Fuze Health, AnewHealth, Drugs.com, PillPack, and Capsule (Delaware) are some of the 9 competitors of Alto Pharmacy.
-
When was Alto Pharmacy acquired?
Alto Pharmacy was acquired on 21-May-2025.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
